Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: MCM family in HCC: MCM6 indicates adverse tumor features and poor outcomes and promotes S/G2 cell cycle progression

Fig. 5

Cell cycle distribution affcted by MCM6. Huh7 cells tranfected with 50 nM Si-MCM6 or negative control (Si-NC) for 48 h. a The cell cycle distribution was determined by flow cytometry in Huh7. b Histograms obtained from flow cytometry measurements show arrest in the S phase in cells treated with Si-MCM6. c CDK2, CDK4, CyclinA, CyclinB1, CyclinD1, and CyclinE were lower in Si-MCM6 treated cells than Si-NC. Data were expressed as the mean of 3 independent experiments. * and§, P < 0.05 compared to control

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us